Pharmacological potential of RNAi — Focus on miRNA
- 1 June 2010
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 126 (3) , 217-227
Abstract
No abstract availableKeywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt
This publication has 174 references indexed in Scilit:
- Alterations of the microRNA network cause neurodegenerative diseaseTrends in Neurosciences, 2009
- Small RNAs as Guardians of the GenomeCell, 2009
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- An Inside Job for siRNAsMolecular Cell, 2008
- RETRACTED: Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and heartsBiochemical and Biophysical Research Communications, 2008
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- The MicroRNA miR-124 Promotes Neuronal Differentiation by Triggering Brain-Specific Alternative Pre-mRNA SplicingMolecular Cell, 2007
- Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphomaInternational Journal of Cancer, 2007
- BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasThe Journal of Pathology, 2005
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005